Close-knit collaboration between our computational, medicinal chemistry, and discovery biology departments sets Verseon apart from other pharmaceutical companies.
A comprehensive chemistry and biology workﬂow integrates with our computational methods, ensuring strict quality standards are met and giving us great program flexibility.
The most promising molecules identified by our computational platform are synthesized and tested in our chemistry and biology labs. We systematically assess and optimize synthesized drug candidate with the help of our computational platform.
Within a few optimization cycles, multiple candidates can be prepared for preclinical studies and clinical development.
From our pool of candidates, we select clinical candidates that have well-rounded efficacy and safety profiles and distinct chemotypes to advance into clinical trials. For every disease program, our workflow is designed to advance several high-quality candidates into clinical trials, thereby increasing our chances of success.